GWW's fourth-quarter 2024 results are likely to reflect gains from upbeat segmental performances and cost-reduction actions.
Vous n'êtes pas connecté
West Pharmaceutical Services eyes fourth-quarter growth amid pharma stabilization, biologics rebound & contract manufacturing gains. Can WST sustain its momentum?
GWW's fourth-quarter 2024 results are likely to reflect gains from upbeat segmental performances and cost-reduction actions.
A robust segmental performance is likely to have benefited RSG's top line in the fourth quarter of 2024.
GEHC's fourth-quarter results are likely to reflect mixed segmental performance in imaging, advanced visualization solutions and patient care. Pharma...
Align Technology reports fourth-quarter 2024 revenue growth. This can be mostly attributed to the robust performance of the Imaging Systems & CAD/CAM...
NHTC reports mixed fourth-quarter 2024 results with steady revenues amid challenges in key markets. New product launches drive optimism for growth.
SYK's fourth-quarter results reflect strong segmental performance, along with a rise in operating margin.
Robust segmental performances are likely to have driven ECL's performance in the fourth quarter.
ADM's fourth-quarter results are likely to show mixed performance, with declines in Ag Services & Oilseeds and growth in Nutrition.
The Trade Desk's fourth-quarter 2024 performance is likely to have benefited from the growing CTV momentum and expanding partner base amid stiff...
Carrier Global's fourth-quarter 2024 performance is expected to have benefited from strong HVAC growth and solid aftermarket services, despite...